LEENO Industrial (058470) Q3 2024 earnings summary

Executive summary

• Manufactures and sells semiconductor test probes (LEENO PIN), IC test sockets, and medical device components, with a strong export focus and proprietary technology.

• 2024 Q3 YTD sales: IC test sockets 60.17% of revenue, LEENO PIN 28.40%, medical device components 10.37%.

• Maintains a robust R&D pipeline, focusing on advanced semiconductor and medical device testing solutions.

Financial highlights

• 2024 Q3 YTD revenue: ₩194.8B, down from ₩255.6B in 2023 and ₩322.4B in 2022.

• Operating income: ₩87.2B (2024 Q3 YTD), down from ₩114.4B (2023) and ₩136.6B (2022).

• Net income: ₩75.0B (2024 Q3 YTD), down from ₩110.9B (2023) and ₩114.4B (2022).

• Basic and diluted EPS: ₩4,940 (2024 Q3 YTD), compared to ₩7,308 (2023).

• Cash and cash equivalents: ₩43.3B as of Q3 2024.

Outlook and guidance

• Plans to maintain a dividend payout ratio of around 30% of net income, subject to business performance.

• Expects continued growth in semiconductor and medical device markets, driven by global trends in AI, 5G, and healthcare innovation.